These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Early use of heparin and thrombolytic drugs in thrombosis and embolism of different localization]. Bukhalovskiĭ IN; Morar' DI Sov Med; 1980; (3):114-5. PubMed ID: 6445597 [No Abstract] [Full Text] [Related]
5. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Monreal M; Lafoz E; Olive A; del Rio L; Vedia C Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic role of heparin in acute pulmonary embolism. Thomas DP Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):21-33. PubMed ID: 808387 [No Abstract] [Full Text] [Related]
7. Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism? Sharma GK Arch Intern Med; 2000 Jul; 160(13):2065-6. PubMed ID: 10888989 [No Abstract] [Full Text] [Related]
8. A heparin symposium. Wessler S Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):3-5. PubMed ID: 808388 [No Abstract] [Full Text] [Related]
9. [The treatment of embolism and thrombosis of the pulmonary artery]. Rzaev NM Khirurgiia (Mosk); 1966 Nov; 42(11):109-14. PubMed ID: 6002524 [No Abstract] [Full Text] [Related]
10. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?]. Ruiz Manzano J; Monreal M Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434 [No Abstract] [Full Text] [Related]
12. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123 [TBL] [Abstract][Full Text] [Related]
13. Heparin: an overview. Maguire FW Del Med J; 1979 Aug; 51(8):439-49. PubMed ID: 385374 [No Abstract] [Full Text] [Related]
14. Sources of error in heparin therapy of thromboembolic disease. Hattersley PG; Mitsuoka JC; King JH Arch Intern Med; 1980 Sep; 140(9):1173-5. PubMed ID: 7406615 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulants: the state of the art. Gallus AS Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989 [TBL] [Abstract][Full Text] [Related]
16. [Studies on 238 fatal lung embolisms in the Freiburg Surgical University Hospital (1952-1963)]. Lorenz D; Ruppin H Med Welt; 1967 Jun; 23():1441-5. PubMed ID: 5617426 [No Abstract] [Full Text] [Related]
17. Control of heparin therapy. Wessler S; Gitel S Prog Hemost Thromb; 1976; 3():311-29. PubMed ID: 781735 [No Abstract] [Full Text] [Related]
18. Prophylaxis of venous thromboembolism by aspirin, warfarin and heparin in patients with hip fracture. A prospective clinical study with cost-benefit analysis. Alho A; Stangeland L; Røttingen J; Wiig JN Ann Chir Gynaecol; 1984; 73(4):225-8. PubMed ID: 6439100 [TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of pulmonary thromboembolism]. Nagata H; Kawakami Y Kokyu To Junkan; 1989 Sep; 37(9):961-5. PubMed ID: 2512601 [No Abstract] [Full Text] [Related]
20. Extensive pulmonary embolism associated with lupus anticoagulant. Jaffe WM; Wattie WJ; Rutland MD; Lubbe WF N Z Med J; 1985 Mar; 98(775):184-5. PubMed ID: 3920589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]